BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Conference Call March 3, 2025 8:00 AM ET
Company Participants
Troy Wichterman – Chief Financial Officer
Rod de Greef – Chairman and Chief Executive Officer
Conference Call Participants
Matthew Stanton – Jefferies
Anna Snopkowski – KeyBanc Capital Markets
Chad Wiatrowski – TD Cowen
Matt Hewitt – Craig-Hallum Capital Group
Thomas Flaten – Lake Street Capital Markets
Michael Okunewitch – Maxim Group
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions’ Q4 2024 Shareholder and Analyst Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. As a reminder, today’s call is being recorded.
I would now like to turn the conference call over to Troy Wichterman, Chief Financial Officer of BioLife Solutions. Please go ahead.
Troy Wichterman
Thank you, operator. Good morning, everyone, and thank you for joining the BioLife Solutions’ 2024 fourth quarter earnings conference call. On this call, we will cover business highlights, financial performance for the quarter and full year 2024, and present 2025 revenue guidance. Earlier today, we issued a press release announcing our financial results and operational highlights for the fourth quarter and full year of 2024 and 2025 revenue guidance, which is available at biolifesolutions.com.
As a reminder, during this call, we will make forward-looking statements. These statements are subject to risks and uncertainties that can be found in our SEC filings. These statements speak only as of the date given, and we undertake no obligation to update them. We will also speak to non-GAAP or adjusted results. Reconciliations of GAAP to non-GAAP or adjusted financial metrics are included in the press release we issued this afternoon.
Now I’d like to turn the call over to Rod
